Literature DB >> 28061953

Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international.

Carolina Geadas1, Sonia K Stoszek2, David Sherman3, Bruno B Andrade4, Sudha Srinivasan5, Carol D Hamilton6, Jerrold Ellner7.   

Abstract

RePORT International is a collaborative research network of investigators from multiple countries and institutions with the goal of establishing a bio-repository of specimens and clinical data for the study of active TB and latent TB infection (LTBI). During the first meeting of RePORT International in Boston, Massachusetts, the results of research pertinent to TB control and eradication were presented, including advances in the research of Mycobacterium tuberculosis (MTB) persistence and drug resistance, TB diagnostics, drug and vaccine development.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Advances; RePORT; Research; Tuberculosis

Mesh：

Substances：

Year:  2016        PMID： 28061953      PMCID： PMC9067314          DOI： 10.1016/j.tube.2016.11.006

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN： 1472-9792            Impact factor:   2.973


  55 in total

1.  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

Authors:  Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin
Journal:  Science       Date:  2006-02-23       Impact factor: 47.728

2.  NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy.

Authors:  Mirjam Schenk; Stephan R Krutzik; Peter A Sieling; Delphine J Lee; Rosane M B Teles; Maria Teresa Ochoa; Evangelia Komisopoulou; Euzenir N Sarno; Thomas H Rea; Thomas G Graeber; Soohyun Kim; Genhong Cheng; Robert L Modlin
Journal:  Nat Med       Date:  2012-03-25       Impact factor: 53.440

3.  IL-32 is a molecular marker of a host defense network in human tuberculosis.

Authors:  Dennis Montoya; Megan S Inkeles; Phillip T Liu; Susan Realegeno; Rosane M B Teles; Poorva Vaidya; Marcos A Munoz; Mirjam Schenk; William R Swindell; Rene Chun; Kathryn Zavala; Martin Hewison; John S Adams; Steve Horvath; Matteo Pellegrini; Barry R Bloom; Robert L Modlin
Journal:  Sci Transl Med       Date:  2014-08-20       Impact factor: 17.956

4.  Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Shaobin Shang; Crystal A Shanley; Megan L Caraway; Eileen A Orme; Marcela Henao-Tamayo; Laurel Hascall-Dove; David Ackart; Ian M Orme; Diane J Ordway; Randall J Basaraba
Journal:  Vaccine       Date:  2012-01-11       Impact factor: 3.641

Review 5.  Mycobacterial Lipidomics.

Authors:  Emilie Layre; Reem Al-Mubarak; John T Belisle; D Branch Moody
Journal:  Microbiol Spectr       Date:  2014-06

6.  Heme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis.

Authors:  Bruno B Andrade; Nathella Pavan Kumar; Eduardo P Amaral; Nicolas Riteau; Katrin D Mayer-Barber; Kevin W Tosh; Nolan Maier; Elisabete L Conceição; Andre Kubler; Rathinam Sridhar; Vaithilingam V Banurekha; Mohideen S Jawahar; Theolis Barbosa; Vincent C Manganiello; Joel Moss; Joseph R Fontana; Beatriz E Marciano; Elizabeth P Sampaio; Kenneth N Olivier; Steven M Holland; Sharon H Jackson; Mahtab Moayeri; Stephen Leppla; Irini Sereti; Daniel L Barber; Thomas B Nutman; Subash Babu; Alan Sher
Journal:  J Immunol       Date:  2015-08-12       Impact factor: 5.422

7.  HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling.

Authors:  Rachel P J Lai; Graeme Meintjes; Katalin A Wilkinson; Christine M Graham; Suzaan Marais; Helen Van der Plas; Armin Deffur; Charlotte Schutz; Chloe Bloom; Indira Munagala; Esperanza Anguiano; Rene Goliath; Gary Maartens; Jacques Banchereau; Damien Chaussabel; Anne O'Garra; Robert J Wilkinson
Journal:  Nat Commun       Date:  2015-09-24       Impact factor: 14.919

8.  Mapping and manipulating the Mycobacterium tuberculosis transcriptome using a transcription factor overexpression-derived regulatory network.

Authors:  Tige R Rustad; Kyle J Minch; Shuyi Ma; Jessica K Winkler; Samuel Hobbs; Mark Hickey; William Brabant; Serdar Turkarslan; Nathan D Price; Nitin S Baliga; David R Sherman
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

9.  Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease.

Authors:  Bruno B Andrade; Nathella Pavan Kumar; Katrin D Mayer-Barber; Daniel L Barber; Rathinam Sridhar; Vaithilingam V Banu Rekha; Mohideen S Jawahar; Thomas B Nutman; Alan Sher; Subash Babu
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

10.  Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis.

Authors:  Catherine Vilchèze; Yossef Av-Gay; Rodgoun Attarian; Zhen Liu; Manzour H Hazbón; Roberto Colangeli; Bing Chen; Weijun Liu; David Alland; James C Sacchettini; William R Jacobs
Journal:  Mol Microbiol       Date:  2008-07-21       Impact factor: 3.501
View more
  4 in total

1.  Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting.

Authors:  Yuri F van der Heijden; Fareed Abdullah; Bruno B Andrade; Jason R Andrews; Devasahayam J Christopher; Julio Croda; Heather Ewing; David W Haas; Mark Hatherill; C Robert Horsburgh; Vidya Mave; Helder I Nakaya; Valeria Rolla; Sudha Srinivasan; Retna Indah Sugiyono; Cesar Ugarte-Gil; Carol Hamilton
Journal:  Tuberculosis (Edinb)       Date:  2018-10-01       Impact factor: 3.131

Review 2.  The pathogenesis of post-primary tuberculosis. A game changer for vaccine development.

Authors:  Robert Hunter; Jeffrey Actor
Journal:  Tuberculosis (Edinb)       Date:  2019-04-26       Impact factor: 3.131

3.  Comorbidities in pulmonary tuberculosis cases in Puducherry and Tamil Nadu, India: Opportunities for intervention.

Authors:  Natasha S Hochberg; Sonali Sarkar; C Robert Horsburgh; Selby Knudsen; Jane Pleskunas; Swaroop Sahu; Rachel W Kubiak; S Govindarajan; Padmini Salgame; Subitha Lakshminarayanan; Amsaveni Sivaprakasam; Laura F White; Noyal Maria Joseph; Jerrold J Ellner; Gautam Roy
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

4.  What's coming for health science and policy in 2018? Global experts look ahead in their field.

Authors:  Soumya Swaminathan; Robin S Room; Louise C Ivers; Graham Hillis; Rebecca F Grais; Zulfiqar A Bhutta; Peter Byass
Journal:  PLoS Med       Date:  2018-01-30       Impact factor: 11.069
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.